Cargando…

Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba

BACKGROUND: Despite a rising incidence of inflammatory bowel disease (IBD) in Hispanics in the United States, there are no studies examining the relationship between immigrant generation and IBD onset among Hispanics. AIMS: To determine whether age of IBD diagnosis, time from immigration to IBD diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damas, O. M., Avalos, D. J., Palacio, A. M., Gomez, L., Quintero, M. A., Deshpande, A. R., Sussman, D. A., McCauley, J. L., Lopez, J., Schwartz, S. J., Abreu, M. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Inflammatory Bowel Disease after Migration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001638/ https://www.ncbi.nlm.nih.gov/pubmed/28524546 http://dx.doi.org/10.1111/apt.14145

Ejemplares similares

Interventions to improve immigrant health. A scoping review
por: Diaz, Esperanza, et al.
Publicado: (2017)

The importance of health behaviours and especially broader self-management abilities for older Turkish immigrants
por: Cramm, Jane M, et al.
Publicado: (2018)

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries
por: Aniwan, Satimai, et al.
Publicado: (2022)

The perception of youth health centres’ friendliness: does it differ between immigrant and Swedish-Scandinavian youths?
por: Baroudi, Mazen, et al.
Publicado: (2020)

Do individuals’ attitudes toward immigrants affect their own health? Analysis of 15 European countries
por: Pinillos-Franco, Sara, et al.
Publicado: (2021)

Naturalization of immigrants and perinatal mortality
por: Minsart, Anne-Frederique, et al.
Publicado: (2013)

Investigating the salmon bias effect among international immigrants in Sweden: a register-based open cohort study
por: Dunlavy, Andrea, et al.
Publicado: (2022)

Migration-related changes in smoking among non-Western immigrants in France
por: Khlat, M, et al.
Publicado: (2019)

Infant mortality among native-born children of immigrants in France, 2008–17: results from a socio-demographic panel survey
por: Wallace, Matthew, et al.
Publicado: (2020)

Differences in the risk of premature cancer mortality between natives and immigrants in Spain
por: Grande, Rafael, et al.
Publicado: (2023)

Kidney transplantation and withdrawal rates among wait-listed first-generation immigrants in Italy
por: Grossi, Alessandra Agnese, et al.
Publicado: (2022)

Latinx trans immigrants’ survival of torture in U.S. detention: A qualitative investigation of the psychological impact of abuse and mistreatment
por: Minero, Laura P., et al.
Publicado: (2021)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
por: Kiesslich, R, et al.
Publicado: (2011)

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway
por: Leinonen, Maarit K., et al.
Publicado: (2017)

Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial
por: Cozijnsen, M A, et al.
Publicado: (2016)

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
por: Rosario, M., et al.
Publicado: (2015)

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
por: Cani, P D, et al.
Publicado: (2009)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up
por: Lansdorp, Corine A., et al.
Publicado: (2022)

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
por: Panaccione, R, et al.
Publicado: (2013)

Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
por: Oancea, I, et al.
Publicado: (2017)

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
por: Sandborn, W. J., et al.
Publicado: (2015)

Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease
por: Manon‐Jensen, T., et al.
Publicado: (2021)

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
por: Kruis, W, et al.
Publicado: (2009)

Relapse after withdrawal from anti‐TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta‐analysis
por: Kennedy, N. A., et al.
Publicado: (2016)

Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers
por: Roberts, Carol L, et al.
Publicado: (2010)

Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease
por: Koelink, Pim J, et al.
Publicado: (2014)

SARS‐CoV‐2 and immunosuppressors at cellular level: Some good news
por: Abreu, Candida
Publicado: (2023)

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling
por: Koelink, Pim J, et al.
Publicado: (2020)

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
por: Kamm, M A, et al.
Publicado: (2008)

Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer
por: Corfe, Bernard M, et al.
Publicado: (2015)

Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial
por: Feagan, B. G., et al.
Publicado: (2016)

Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse
por: Arrieta, M C, et al.
Publicado: (2008)

Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
por: Thomas, Pepijn W. A., et al.
Publicado: (2021)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
por: Travis, Simon P L, et al.
Publicado: (2011)

Mouse Paneth cell antimicrobial function is independent of Nod2
por: Shanahan, Michael T, et al.
Publicado: (2014)

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
por: Wang, Ming-Hsi, et al.
Publicado: (2023)

High prevalence of ulcerative appendicitis in patients with ulcerative colitis
por: Heuthorst, Lianne, et al.
Publicado: (2021)

Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse
por: Robinson, A, et al.
Publicado: (2013)

Evolutionary history of human colitis-associated colorectal cancer
por: Baker, Ann-Marie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4nlcdvjt71g501bnfvdgc1uc1f